Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-24-006562

EVP R&D, Chief Medical Officer gave up 5,452 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 12,278 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-22 Exercise or conversion : show line 1 in the form +12,278 110,886 D
2024-02-22 Shares withheld for taxes : show line 2 in the form −5,452 $28.91 $157,617 105,434 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-22 Exercise or conversion : show line 3 in the form Restricted Stock Unit Award −12,278 12,279 D
Loading xslF345X05/form4.xml…